Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
64,481,859
-
Shares change
-
+5,808,580
-
Total reported value, excl. options
-
$3,936,264,424
-
Value change
-
+$367,756,283
-
Put/Call ratio
-
117%
-
Number of buys
-
181
-
Number of sells
-
-84
-
Price
-
$61.04
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2020
332 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q2 2020.
BLUEBIRD BIO INC - COM (BLUE) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,481,859 shares
.
Largest 10 shareholders include Capital Research Global Investors (8,094,771 shares), WELLINGTON MANAGEMENT GROUP LLP (7,239,982 shares), VANGUARD GROUP INC (6,097,060 shares), BlackRock Inc. (3,993,061 shares), Capital World Investors (3,470,784 shares), SANDS CAPITAL MANAGEMENT, LLC (3,130,551 shares), ROYAL BANK OF CANADA (2,619,978 shares), STATE STREET CORP (1,642,482 shares), VICTORY CAPITAL MANAGEMENT INC (1,531,251 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,440,641 shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.